Formulierung gegen Krebs

Patent europeic · EP2343051 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2343051
Numer da la dumonda
EP11150003
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
02-01-2011
Publitgà
13-07-2011
Concedì
30-07-2014
La protecziun finescha il pli tard
01-01-2031
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61K 9/00 (2006.01)
A61K 47/34 (2006.01)
A61K 31/343 (2006.01)
A61K 9/22 (2006.01)
Prioritad
US 292311 P 05.01.2010
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-02-2026

    Midada

    Published in Swissreg on 01.02.2026

  2. 01-02-2025

    Midada

    Published in Swissreg on 01.02.2025

  3. 01-02-2024

    Midada

    Published in Swissreg on 01.02.2024

  4. 01-02-2023

    Midada

    Published in Swissreg on 01.02.2023

  5. 30-07-2014

    Concedì

    Published in Swissreg on 30.07.2014

Partidas

Possessur

National Dong Hwa University

No. 1, Sec. 2, Da Hsueh Rd Shoufeng, Hualien, TW

Inventur

Chiou, Tzyy-Wen

Hualien 97051, TW

Harn, Horng-Jyh

Taipei, TW

Lin, Shinn-Zong

Taichung 40447, TW

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.